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Abstract:
Objective:  To test the efficacy of Chiropractic spinal
manipulative therapy (SMT) in the treatment of migraine,
using an uncontrolled clinical trial.
Design:  A clinical trial of six months duration.  The trial
consisted of 3 stages:  two months of pre-treatment, two
months of treatment, and two months post treatment.
Comparison was made to initial baseline episodes of
migraine preceding commencement of SMT.
Setting:  Chiropractic Research Centre of Macquarie
University
Participants:  Thirty two volunteers, between the ages of
23 to 60 were recruited through media advertising.  The
diagnosis of migraine based on a detailed questionnaire,
regarding self reported symptoms or signs, with minimum
of one migraine with aura per month.
Interventions:  Two months of SMT provided by an
experienced chiropractor at a university clinic.
Main Outcome Measures:  Participants completed diaries
during the entire trial noting the frequency, intensity,
duration, disability, associated symptoms and use of
medication for each migraine episode.  In addition, clinic
records were compared to their diary entries of migraine
episodes.
Results:  A total of fifty nine participants responded to the
advertising, with twenty five being excluded or deciding
not to continue in the trial.  Two participants (5.9%)
withdrew during the trial, one due to alteration in work
situation and one following soreness after SMT.  The
Chiropractic SMT group showed statistically significant
improvement (p < 0.05) in migraine frequency and
duration, when compared to initial baseline levels.  Only
one participant (3.1%) reported that the migraine episodes
were worse after the two months of SMT, and this was not
sustained at the two month post treatment follow up
period.
Conclusion:  The results of this study suggest that
Chiropractic SMT is an effective treatment for migraine
with aura.  However, due to the cyclical nature of migraine
with aura, and the finding that episodes usually reduce
following any intervention, further research is required.
A prospective randomised controlled trial utilising detuned
EPT (interferential), a sham manipulation group and an
SMT group is nearing conclusion.  It is anticipated this
trial will provide further information of the efficacy of
Chiropractic SMT in the treatment of migraine with
aura.
Key Indexing Terms (MeSH): Migraine, chiropractic,
spinal manipulation, clinical trial.
INTRODUCTION
Some studies appear to have demonstrated significant
reduction in migraines following chiropractic intervention
(1-8).  However, this reduction may in part have been due
to inaccurate diagnosis or overlapping symptoms (4,9,10).
Many different conditions of the cervical spine, including
mechanical and joint pathology, have been reported to
cause headache (10-16).  Sjaastad (17) used the term
“cervicogenic headache” to describe a type of the chronic
paroxysmal unilateral headache, which is accompanied
by autonomic symptoms and provacated by movements of
the head and neck.  Sjaastad proposed that entrapment of
the occipital nerve or a C2-C3 rhizopathy may produce
this headache (18).
There are a number of aetiologies of migraines proposed
in the literature.  These include:  vascular (19-21);
autonomic (22); biochemical/cellular/immunological (23-
27); psychophysiological (28,29); neurogenic (9,15,25,30)
and somatic (1-9,31,32).  This has made a common
treatment regime difficult.  One early medical model was
vascular cause of migraine, where a migrainous attack is
initiated by a decreased blood flow to the cerebral
vasculature or a cerebrovascular spasm, but characterized
by extracranial vasodilation during the headache phase
(19,20).  However, later aetiological models have
demonstrated more complex vascular changes with
associated neurological changes (9).
Many practitioners involved in the treatment of migraine
would, however, accept that a number of aetiological
factors are involved and that there is substantial overlap
in both aetiology or diagnosis (9,15,26,33,34).  In addition,
no single model appears to explain all the possible
symptoms associated with migraine.
One possible aetiological factor is cervical spondylosis
with associated neck pain and stiffness (34).  Anthony
states “when this is recognised, appropriate treatment
can give impressive results...the aim is to relieve pressure
on nerve roots in the upper neck thereby reducing
activation of the spinal tract of the trigeminal nerve,
which is part of the pain centre in the head and neck”
(34).  Surgical decompression of the lower cervical nerve
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roots as carried out by Ghavamian (36) showed relief of
migraine symptoms.  He proposed that irritation and
compression of the deep sympathetic fibres incited such
symptomatology.
Vernon (7), proposed a vertebrogenic model which
involves components from the different categories
previously stated.  One part involves lesions in the low
cervical/upper thoracic spine and the upper cervical
spine.  The low cervical spine/upper thoracic spine
(C7-T4) model proposed that dysfunction (i.e. somatic
dysfunction) at these vertebral levels causes joint fixation
and pain.  This pain alters the neural messages received,
and therefore sent, by the Central Nervous System (CNS).
The Autonomic Nervous System which controls, amongst
other functions, blood supply, is thus also affected.  It is
proposed that when certain threshold levels of transient
cerebral ischaemia (due to vasoconstriction caused by the
above mechanism) are reached, a migraine cascade of
symptomatology may be precipitated.
A second part involves somatic dysfunction in the upper
cervical spine (Occiput-C2), which produces local pain
and fixation leading to increased neural input to the CNS.
This results in a reduction in descending pain-inhibiting
impulses from the CNS and consequently increases activity
within the spinal trigeminal tract (which transmits the
majority of sensory afferents and pain signals from the
upper cervical region to the brain).  Having exceeded a
threshold level, this excessive afferent input to the CNS
will trigger focal, and spreading vasoconstriction within
the intracerebral vasculature.  This will in turn promote
extra-carotid vasodilation and cranial pain which is
mediated by the ipsilateral trigeminal nerve (7).
Another model contends that irritation of the vertebral
nerve by cervical lesions can produce a sympathetic
syndrome, giving symptoms of headache, vertigo, visual
disturbances and tinnitus.  However, this model has not
been well substantiated and appears more likely a cause
of vascular headache as opposed to migraine (11).  The
source of pain in migraines is found in the intra- and
extracranial blood vessels.  The blood vessel walls are
pain sensitive to distension, traction or displacement.
The idiopathic dilation of cranial blood vessels, together
with an increase in a pain threshold lowering substance,
result in headache of migraine type (26).
Migraine has a well established symptomatology that has
been outlined in various studies (4,12,15).  The debilitating
and frequent nature of symptoms that include head pain,
nausea, vomiting, phonophobia, and photophobia, costs
our society both socially and economically (4,12,15,20).
As such, effective treatment has long been sought, therefore
justifying study in this area.  However, there is substantial
overlap of symptoms between migraine and cervicogenic
headache, and some authors believe elements of the
migraine headache continuum involve cervical headache
(9,10).
The Headache Classification Committee of the
International Headaches Society, has discarded the former
terms classical migraine and common migraine in favour
of migraine with aura and migraine without aura.  In
migraine with aura (MA), this condition is defined as
recurrent, periodic, unilateral headache which is preceded
or accompanied by transient visual, sensory, motor, or
other focal neurological symptoms which localise to the
cerebral cortex or brainstem.  Migraine without aura,
(MWA) is defined as a vascular headache without striking
prodromal or associated symptoms of cerebral dysfunction
(37).
The incidence of migraine in Australia is estimated at
12%, with the cost to industry an estimated $250 million
(38).  In the USA approximately 8% of headaches
diagnosed by medical practitioners are called migraine
headaches (39).  Migraine, in its various forms, affects an
estimated 5-20% of people throughout the world (40).
A review of the literature appears to indicate that migraine
is an associated feature of cervical dysfunction.  This
paper will evaluate chiropractic spinal manipulative
treatment directed towards improving vertebral function,
and its role in the management of the migraines.
METHODOLOGY
Chiropractic spinal manipulative therapy (SMT) is defined
as a passive manual manoeuvre during which the three
joint complex is carried beyond the normal physiological
range of movement without exceeding the boundaries of
anatomical integrity (41).  SMT requires a dynamic force
in a specific direction, usually with a short amplitude, to
correct a problem of reduced vertebral motion or positional
fault.
The study design was based on a previous study which
involved 82 subjects who received either chiropractic
SMT, physiotherapy manipulation, or a control treatment
of medical mobilization (1).  Parker et al, concluded that
manipulation was not found to be more effective than
mobilisation, and chiropractic treatment not more effective
than the other two groups (3).  However, much criticism
was received over the study, especially the statistical
analysis (42).
People with migraines were advertised for participation
in the study via the radio and newspapers within a local
region of Sydney.  All applicants completed a
questionnaire, developed from Vernon (12), which
contains over 25 sections, including details of the initial
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history, frequency, severity, location and reaction to the
pain, associated symptoms, precipitating or aggravating
factors, relieving factors, past treatment for migraines,
medical history including medications and other
diagnostic tests.
The participants to take part in the trial were selected
according to responses in the questionnaire of specific
symptoms.  The criteria for migraine diagnosis was
compliance with at least 5 out of the following indicators:
reaction to pain requiring cessation of activities or the
need to seek a quiet dark area; pain located around the
temples; pain described as throbbing; associated symptoms
of nausea, vomiting, aura, photophobia or phonophobia;
migraine precipitated by weather changes; migraine
aggravated by head or neck movements; previous diagnosis
of migraine by a specialist; and a family history of
migraine.
Participants also had to experience migraine at least once
a month, but not daily, and the migraines could not have
been initiated by trauma.  Participants were excluded
from the study if there were contra-indications to SMT,
such as meningitis or cerebral aneurysm.  In addition,
participants with temporal arteritis, benign intracranial
hypertension or space occupying lesions, were also
excluded due to safety aspects.
Participants were informed that they were involved in a
trial of manipulative therapy for migraine, and that they
may be randomly assigned to a control group which
would receive a placebo (non effective) treatment, or to an
intervention group which would receive Chiropractic
SMT.  However, because of the small numbers of
participants that were involved in the trial, a control
group was not used.  Participants were also informed that
a thorough physical examination would be performed
prior to commencement of treatment to assess any physical
problems precluding them receiving SMT.  Patients were
blinded, by believing that they may or may not receive an
effective treatment.  In addition, practitioners were not
aware of ongoing treatment results, therefore they were
also “blinded” to the stage of progress of the patients
condition or response to treatment.
The trial was conducted over six months, and consisted
of 3 stages:  two months pretreatment, two months
treatment, and two months post treatment.  Participants
completed diaries during the entire trial noting the
frequency, intensity, duration, disability, associated
symptoms and use of medication for each migraine
episode.  In addition, clinic records were compared to
their diary entries of migraine episodes.  Concurrently,
the subjects were contacted by telephone by the author
every month and asked to describe the migraine episodes
for comparison to their diaries.
Patients were instructed at the beginning of the study on
the use of the diary and were given an instruction sheet to
use throughout the course of the trial.  The diary consisted
of a table for entries of each of the outcome measures.
This included noting the date of each episode, a number
representing a visual analogue score, letters denoting
associated symptoms, the length (in hours) of each
migraine, the time (in hours) before the person could
return to normal duties, type and use of medications and
the overall relief from the medication.  The diaries were
modified from standard diaries used by the Brain
Foundation of Australia.
A detailed history of the patient's subjective pain features
was taken during the initial consultation.  This included
the type of pain, duration, onset, severity, radiation,
aggravating and relieving factors.  The history also
included medical features, a systems review for potential
pathologies, previous treatments and its effects.
Factors for assessing subluxation included:  orthopaedic
and neurological testing, segmental springing, mobility
measures such as visual estimation of range of motion,
assessment of previous radiographs, specific chiropractic
vertebral testing procedures, as well as response of the
patient to SMT.
In addition, several vascular investigations were performed
where indicated, which included: vertebral artery test,
manipulative provocation test, blood pressure assessment,
and abdominal aortic aneurysm screening.
During the treatment period, the subjects continued to
record migraine episodes in their diary, and receive
telephone calls from the authors.  Treatment consisted of
short amplitude, high velocity spinal manipulative thrusts,
or areas of fixation determined by the physical
examination.  Patients were allowed a maximum of
sixteen treatments, and the frequency of treatment was
dependent on the clinicians opinion of the severity of the
vertebral dysfunction.  The majority of patients received
a minimum of twelve treatments.
Comparison was made to initial baseline episodes of
migraine preceding commencement of SMT.  Statistical
analysis involved comparing the effects of the different
treatment regimes on the incidence, intensity, and duration
of migraines throughout the trial.  Statistical tests
employed were a students t test to test for significant
difference between each group and a one way analysis of
variance (ANOVA) to test for changes for all groups.
Statistical calculations were performed via a computer
software program Minitab for Macintosh.
RESULTS
A total of fifty nine participants responded to the
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advertising, with twenty five being excluded or deciding
not to continue in the trial.  These included:  six cases of
infrequent recurrence of the migraines (less than one per
month); two cases of contraindications to SMT; one case
of cluster headache; one case of motor vehicle accident
during pre treatment; one case of fear of SMT; fourteen
cases where the university clinic was inconvenient or
time constraints were too difficult for participants.  Two
participants (5.9%) withdrew during the trial, one due to
alteration in work situation and one following soreness
after SMT.
Thirty two participants, between the ages of 23 to 60,
joined the study with there being 14 males and 18
females.  Table 1 gives the comparative descriptive
statistics for the group.
The Chiropractic SMT group showed statistically
significant improvement (p < 0.05) in migraine severity
(Figure 1), duration (Figure 2) and disability (Figure 3),
when compared to initial baseline levels.  Only one
participant (3.1%) reported that their migraine episodes
were worse after the two months of SMT, but this was not
sustained at the two month post treatment follow up
period.  Table 2 demonstrates variate scores in each of the
six diary categories for the three phases of the trial.
The greatest area for improvement was with disability
scores (p < 0.01), where participants were asked to rate
the time that elapsed before they could return to normal
activities (Table 3).  In addition, the duration of the
migraine and the use of medication, reduced significantly
following the SMT intervention (p < 0.05).  Table 3
shows mean variate scores for the three phases of the trial
and statistical significance by analysis
of variance (ANOVA).
There was no apparent difference in
the number of associated symptoms
and the time taken for treatment to give
relief of each migraine episode (Table
3).  In addition, self reported possible
trigger factors demonstrated no
significant findings, predominantly due
to the small sample size.  Common
trigger factors that were cited included
stress, lack of sleep, work changes, or
family situations.  Most participants
could not state a particular trigger
factor.
DISCUSSION
The majority of people who participated
in this trial had chronic migraines that
were severe and debilitating.  However,
the results have demonstrated a
significant (p< 0.05) reduction in their
Table 1:  Comparative descriptive statistics
FACTOR DATA
Total subjects n=32
Sex ratio 14M : 18F
Age range 23 to 60 (mean 39.5)
Frequency (No/month) 1 to 18 (mean 7.6)
Duration (Years) 5 to 36 (mean 18.1)
Table 2:  Variate scores for the three phases of the trial
GROUP MEASUREMENTS MIN MAX TOTAL MEAN SD
Visual Analogue Score (VAS) 2 124 1691 52.8 35.3
Associated Symptoms 6 36 431 13.5 6.9
Duration 8 401 5970 186.6 114.7
Disability 7 28 502 15.7 4.7
Medication(s) 8 39 529 16.5 6.9
Relief 22 82 1182 36.9 13.9
VAS 8 84 1429 44.7 19.1
Associated Symptoms 5 35 399 12.5 6.9
Duration 6 370 5087 158.9 110
Disability 5 36 433 13.5 7.3
Medication(s) 4 34 471 14.7 7.5
Relief 10 82 1094 34.2 12.7
VAS 4 79 1120 35 19.5
Associated Symptoms 7 37 463 14.5 6.9
Duration 4 363 3837.5 119.9 83.7
Disability 3 23 342 10.7 4.7
Medication(s) 3 33 386 12.1 6.9
Relief 22 82 1182 36.7 13.9
Pre-
Treatment
Treatment
Post-
treatment
VARIATES PRE-TREATMENT TREATMENT POST-TREATMENT p VALUES
VAS 52.8 44.7 35 <0.05
Associated Symptoms 13.5 12.5 14.5 NS
Duration 186.6 158.9 119.9 <0.05
Disability Scores 15.7 13.5 10.7 <0.01
Medications 16.5 14.7 12.1 <0.05
Relief Scores 36.9 34.2 36.7 NS
Table 3:  Mean variate scores for the three phases of the trial and statistical 
significance by analysis of variance (ANOVA).
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migraine episodes and their associated disability.  The
mean number of migraine per month reduced from 7.6 to
4.9 episodes.
This trial was conducted using a similar design to a
previous study which demonstrated significant
improvement in migraines following chiropractic SMT
(1,3).  The initial trial had limitations due to an inadequate
control group, and this could also be a limitation with this
study(2).  However, the use of self reported, non treatment
period as a control, allows flexibility regarding use of
medication and any alteration during the trial.
Figure 1:  Comparison of visual analogue scores for pre-
treatment, treatment and post-treatment group means
Figure 2:  Comparison of duration time of migraine (hours) for
pre-treatment, treatment and post-treatment group means
Figure 3:  Comparison of disability time of migraine (hours)
for pre-treatment, treatment and post-treatment group means
A similar design to this study has also been used in a study
of headache and SMT (14).  The Boline study was a
randomised controlled trial using two parallel groups,
with a two week baseline, a six week treatment period and
a four week post treatment period.  The results of this
study show that SMT was an effective method of treatment
for tension type headaches, and that the benefit was
sustained for the four weeks after cessation of the treatment.
The present study was conducted over a six month period
which gives the results substantial significance because
early criticisms of studies were that the length of the trial
was too short to allow for the cyclical nature of migraines.
However, the study is limited in the sample size and the
fact that the trial was a pragmatic study which did not
consider what aspects of chiropractic SMT had contributed
to the improvement in the migraine episodes.
In addition, the study is limited due to the lack of a control
group.  However, the fact that the trial was conducted over
a six month period, with two months pre-treatment, it
could be argued that participants acted as their own form
of control.
A further limitation of this study, as with other studies of
migraine or headaches is that there is substantial overlap
in diagnosis and classification of migraines.  The
questionnaire used in this study proved to have good
reliability, however, there is strong suggestion that many
headache sufferers may have more than one type of
headache (12).  An advantage with the design of this
study is that regardless of the exact “diagnosis” of the
migraine, self reported, non-treatment controls still allow
assessment of the therapy in question.
The measurement used for relief scores proved to be poor,
which was probably due in part to the small scale for
response that participants were given.  Future studies
should address this issue.  In addition, associated symptoms
did not give a clear result because the study only measured
the total number of associated symptoms, and the sample
size was too small for a significant percentage breakdown.
Future studies should also address this issue.
CONCLUSION
The results of this study suggest that Chiropractic SMT
may be an effective treatment for migraine.  However, due
to the cyclical nature of migraine, and the finding that
episodes usually reduce following any intervention, further
research is required.  A prospective randomised controlled
trial utilising detuned EPT (interferential), a sham
manipulation group and an SMT group is nearing
0
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conclusion.  It is anticipated this trial will provide further
information of the efficacy of Chiropractic SMT in the
treatment of migraine.
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